Ho RL - Search Results

1

Prospective randomized control study on the effect of branched-chain amino acids in patients with liver resection for hepatocellular carcinoma.

Meng WC, Leung KL, Ho RL, Leung TW, Lau WY. Meng WC, et al. Among authors: ho rl. Aust N Z J Surg. 1999 Nov;69(11):811-5. doi: 10.1046/j.1440-1622.1999.01701.x. Aust N Z J Surg. 1999. PMID: 10553972 Clinical Trial.

2

Sorafenib inhibits hypoxia-inducible factor-1α synthesis: implications for antiangiogenic activity in hepatocellular carcinoma.

Liu LP, Ho RL, Chen GG, Lai PB. Liu LP, et al. Among authors: ho rl. Clin Cancer Res. 2012 Oct 15;18(20):5662-71. doi: 10.1158/1078-0432.CCR-12-0552. Epub 2012 Aug 28. Clin Cancer Res. 2012. PMID: 22929805

3

ZBP-89 enhances Bak expression and causes apoptosis in hepatocellular carcinoma cells.

To AK, Chen GG, Chan UP, Ye C, Yun JP, Ho RL, Tessier A, Merchant JL, Lai PB. To AK, et al. Among authors: ho rl. Biochim Biophys Acta. 2011 Jan;1813(1):222-30. doi: 10.1016/j.bbamcr.2010.09.005. Epub 2010 Sep 17. Biochim Biophys Acta. 2011. PMID: 20850481 Free PMC article.

4

Adenovirus-mediated tBid overexpression results in therapeutic effects on p53-resistant hepatocellular carcinoma.

Miao J, Chen GG, Chun SY, Yun JP, Chak EC, Ho RL, Lai PB. Miao J, et al. Among authors: ho rl. Int J Cancer. 2006 Oct 15;119(8):1985-93. doi: 10.1002/ijc.22040. Int J Cancer. 2006. PMID: 16708390 Free article.

5

Mutation of p53 in recurrent hepatocellular carcinoma and its association with the expression of ZBP-89.

Chen GG, Merchant JL, Lai PB, Ho RL, Hu X, Okada M, Huang SF, Chui AK, Law DJ, Li YG, Lau WY, Li AK. Chen GG, et al. Among authors: ho rl. Am J Pathol. 2003 Jun;162(6):1823-9. doi: 10.1016/S0002-9440(10)64317-9. Am J Pathol. 2003. PMID: 12759240 Free PMC article.

6

Reduction of double-stranded RNA-activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus.

Chen GG, Lai PB, Ho RL, Chan PK, Xu H, Wong J, Lau WY. Chen GG, et al. Among authors: ho rl. J Med Virol. 2004 Jun;73(2):187-94. doi: 10.1002/jmv.20074. J Med Virol. 2004. PMID: 15122791

7

HBx mutants differentially affect the activation of hypoxia-inducible factor-1α in hepatocellular carcinoma.

Liu LP, Hu BG, Ye C, Ho RL, Chen GG, Lai PB. Liu LP, et al. Among authors: ho rl. Br J Cancer. 2014 Feb 18;110(4):1066-73. doi: 10.1038/bjc.2013.787. Epub 2013 Dec 17. Br J Cancer. 2014. PMID: 24346287 Free PMC article.

8

Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma.

Chen GG, Li MY, Ho RL, Chak EC, Lau WY, Lai PB. Chen GG, et al. Among authors: ho rl. J Clin Virol. 2005 Sep;34(1):7-12. doi: 10.1016/j.jcv.2005.01.006. J Clin Virol. 2005. PMID: 16087118

9

Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC).

Chen GG, Ho RL, Wong J, Lee KF, Lai PB. Chen GG, et al. Among authors: ho rl. Eur J Surg Oncol. 2007 Sep;33(7):882-6. doi: 10.1016/j.ejso.2007.02.036. Epub 2007 Apr 12. Eur J Surg Oncol. 2007. PMID: 17433605

10

Decreased expression of Bid in human hepatocellular carcinoma is related to hepatitis B virus X protein.

Chen GG, Lai PB, Chan PK, Chak EC, Yip JH, Ho RL, Leung BC, Lau WY. Chen GG, et al. Among authors: ho rl. Eur J Cancer. 2001 Sep;37(13):1695-702. doi: 10.1016/s0959-8049(01)00182-4. Eur J Cancer. 2001. PMID: 11527698

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results